Adherence to leukemia maintenance therapy: A comparative study among children, adolescents, and adults

Pediatric Hematology and Oncology

Volumn 29, Issue 5, 2012, Pages 428-439

  Mancini, Julien ^a,b   Simeoni, Marie Claude ^a,b   Parola, Nathalie ^a   Clement, Audrey ^b   Vey, Norbert ^a,c   Sirvent, Nicolas ^d   Michel, Gérard ^a,e   Auquier, Pascal ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b AP HM   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

^e Timone Enfants Hospital   (France)

Author keywords

Acute leukemia; Age groups; Maintenance therapy; Medication adherence; Screening

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATTITUDE TO HEALTH; CHILD; COMORBIDITY; COMPARATIVE STUDY; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG TOLERANCE; FEMALE; FOLLOW UP; HEALTH INSURANCE; HUMAN; LIVER TOXICITY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCHOOL CHILD; SCHOOL CHILD; SOCIAL STATUS; TREATMENT REFUSAL;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES;

EID: 84864856020     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2012.693150     Document Type: Article

References (35)

1. DiMatteoMR. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care. 2004;42:200-209.
2. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002;94:652-661.
3. O'Neill VJ, Twelves CJ.Oral cancer treatment: Developments in chemotherapy and beyond. Br JCancer. 2002;87:933-937.
4. Davies HA, Lennard L, Lilleyman JS. Variable mercaptopurine metabolism in children with leukaemia: A problem of non-compliance? Bmj. 1993;306:1239-1240.
5. de Oliveira BM, Viana MB, Zani CL, Romanha AJ. Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia. Arch Dis Child. 2004;89:785-788.
6. Festa RS, Tamaroff MH, Chasalow F, Lanzkowsky P.Therapeutic adherence to oralmedication regimens by adolescents with cancer. I. Laboratory assessment. J Pediatr. 1992;120:807-811.
7. TamaroffMH,Festa RS, Adesman AR,Walco GA.Therapeutic adherence to oralmedication regimens by adolescents with cancer. II. Clinical and psychologic correlates. J Pediatr. 1992;120:812-817.
8. Lansky SB, Smith SD, Cairns NU, Cairns GF, Jr. Psychological correlates of compliance.AmJPediatr Hematol Oncol. 1983;5:87-92.
9. Lau RC,Matsui D, Greenberg M, Koren G. Electronicmeasurement of compliance withmercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol. 1998;30:85-90.
10. Lennard L,Welch J, Lilleyman JS. Intracellularmetabolites of mercaptopurine in children with lymphoblastic leukaemia: A possible indicator of non-compliance? Br J Cancer. 1995;72:1004-1006.
11. Smith SD, Rosen D, Trueworthy RC, Lowman JT. A reliable method for evaluating drug compliance in children with cancer. Cancer. 1979;43:169-173.
12. Tebbi CK, Cummings KM, ZevonMA, et al. Compliance of pediatric and adolescent cancer patients. Cancer. 1986;58:1179-1184.
13. Lancaster D, Lennard L, Lilleyman JS. Profile of non-compliance in lymphoblastic leukaemia. Arch Dis Child. 1997;76:365-366.
14. PeetersM, Koren G, Jakubovicz D, Zipursky A. Physician compliance and relapse rates of acute lymphoblastic leukemia in children. Clin Pharmacol Ther. 1988;43:228-232.
15. Eden OB, Stiller CA, Gerrard MP. Improved survival for childhood acute lymphoblastic leukemia: Possible effect of protocol compliance. Pediatr Hematol Oncol. 1988;5:83-91.
16. Richardson JL, Shelton DR, KrailoM, Levine AM.Theeffect of compliancewith treatment on survival among patients with hematologicmalignancies. J Clin Oncol. 1990;8:356-364.
17. Levine AM, Richardson JL,Marks G, et al. Compliance with oral drug therapy in patients with hematologicmalignancy. J Clin Oncol. 1987;5:1469-1476.
18. PritchardMT, Butow PN, Stevens MM, Duley JA. Understandingmedication adherence in pediatric acute lymphoblastic leukemia: A review. J Pediatr Hematol Oncol. 2006;28:816-823.
19. KondrynHJ, Edmondson CL,Hill J, Eden TO. Treatment non-adherence in teenage and young adult patients with cancer. Lancet Oncol. 2010;12:100-108.
20. Schiffer CA. Differences in outcome in adolescents with acute lymphoblastic leukemia: A consequence of better regimens? Better doctors? Both? J Clin Oncol. 2003;21:760-761.
21. Knobel H, Alonso J, Casado JL, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA Study. Aids. 2002;16:605-613.
22. Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: Translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51:1013-1023.
23. Sapin C, Simeoni MC, El Khammar M, et al. Reliability and validity of the VSP-A, a health-related quality of life instrument for ill and healthy adolescents. J Adolesc Health. 2005;36:327-336.
24. Simeoni MC, Auquier P, Antoniotti S, et al. Validation of a French health-related quality of life instrument for adolescents: The VSP-A. Qual Life Res. 2000;9:393-403.
25. Spielberger CD, Gorsuch RL, Lushene RE. STAI manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
26. Tournois J, Mesnil F, Kopp JL. Autoduperie et hétéroduperie : Un instrument de mesure de la désirabilité sociale. Revue Européenne de Psychologie Appliquée. 2000;50:219-232.
27. RosenbaumJR,Wells CK, Viscoli CM, et al. Altruism as a reason for participation in clinical trials was independently associated with adherence. J Clin Epidemiol. 2005;58:1109-1114.
28. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
29. Regnier-Denois V, Poirson J, Nourissat A, et al. Adherence with oral chemotherapy: Results from a qualitative study of the behaviour and representations of patients and oncologists. Eur J Cancer Care (Engl). 2011;20:520-527.
30. Pellegrini I, Sarradon-Eck A, Soussan PB, et al. Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: Breast cancer patients' point of view. Psychooncology. 19:472-479.
31. Garner P, Volmink J. Directly observed treatment for tuberculosis. Bmj. 2003;327:823-824.
32. Rivard GE, Infante-Rivard C, Hoyoux C, Champagne J. Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: Better in the evening. Lancet. 1985;2:1264-1266.
33. Atkins L, Fallowfield L. Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer. 2006;42:2271-2276.
34. Lightfoot TJ, JohnstonWT, Simpson J, et al. Survival fromchildhood acute lymphoblastic leukaemia: The impact of social inequality in the United Kingdom. Eur J Cancer. 2012;48:263-269.
35. Cote I, Farris K, Feeny D. Is adherence to drug treatment correlated with health-related quality of life? Qual Life Res. 2003;12:621-633.